Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07866638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair

Study acronym: SOAR
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this prospective is to determinate if Suzetrigine decreased de use of opioids in patients that undergo an arthroscopic rotator cuff repair. The main question it aims to answer: Does Suzetrigine lower the number of times participants need to use opioid? If there is a comparison group: Researchers will compare study drug group to see if, will reduce opioid utilization during the inpatient period and at discharge without worsening pain control, compared with multimodal analgesia alone. Participants will take study drug before procedure and for 13 days afterwards.
Trial Details
NCT Number NCT07866638
Lead Sponsor University of Alabama at Birmingham
Conditions Artroscopic Surgery, Pain Management, Pain After Shoulder Surgery, Opioid Consumption, Opioid Consumption, Postoperative
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov